Optimize Financial’s Eastman Chemical EMN Stock Holding History

Optimize Financial’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,539	Closed	-$232K	–	243
2024 Q4	$232K	Buy	+2,539	New	+$260K	0.17%	183

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Optimize Financial's EMN Position: Q1 2025 in Review

Optimize Financial sold out of Eastman Chemical (EMN) in Q1 2025, closing a stake of 2,539 shares — an estimated $232K sold.

Optimize Financial first reported a position in EMN in Q4 2024 and held it in 1 quarter. The position peaked at $232K in Q4 2024. 806 funds tracked by Wall St. Rank hold EMN as of Q1 2025.

Optimize Financial reported no remaining Eastman Chemical position as of Q1 2025 after selling out during the quarter.
Optimize Financial sold 2,539 Eastman Chemical shares in Q1 2025, an estimated $232K.
Optimize Financial first reported a position in Eastman Chemical in Q4 2024 and held it in 1 quarter.
Optimize Financial's Eastman Chemical position peaked at $232K in Q4 2024.
806 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2025.

Based on Optimize Financial's 13F filing for Q1 2025, filed 14 May 2025.